Clinical Trials Directory

Trials / Completed

CompletedNCT03012932

HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women

HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Miami · Academic / Other
Sex
Female
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

The proposed study will examine the implementation of a Human Papilloma Virus (HPV) self-sampling intervention for under screened LBQ women living in South Florida. The study will enroll participants to receive the self-sampling intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHPV self-samplingAll participants will receive HPV self-sampling intervention. HPV self-sampling is a cervical cancer screening that can be done in private, using a device that is similar to a tampon. This intervention tests for high-risk HPV, the primary cause of cervical cancer. Each participant will complete the intervention one time only.

Timeline

Start date
2017-02-02
Primary completion
2018-03-24
Completion
2018-03-24
First posted
2017-01-06
Last updated
2018-09-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03012932. Inclusion in this directory is not an endorsement.

HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women (NCT03012932) · Clinical Trials Directory